Accessibility Tools

Angamuthu Selvapandiyan

Download CV

Angamuthu Selvapandiyan

Email : selvapandiyan@jamiahamdard.ac.in

View Google Scholar

PERSONAL INFORMATION

Alternate Email :

aselvapandiyan@gmail.com

Designation :

Dean, HOD & Professor

Department & School :

Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology

Qualifications :

Ph.D. FAMS

State Of Domicile :

Delhi

Research Thrust Areas :

Infectious Diseases, Cell Biology, Vaccinolgy, Drug Development

Details Of Courses Taught

Vaccinology, Immunology,Parasitology, Bacteriology, Molecular Biology

PUBLICATIONS

BOOKS & BOOK CHAPTERS PUBLISHED

Number Of Books Published By National Publisher :

The Name Of The Publisher :

Number Of Books Published By International Publisher :

1

 

 

 

 

 

The Name Of The International Publisher :

SPRINGER 

 

 

 

 

Number Of Book Chapters In Edited Books Of National Publishers :

4

 

 

 

 

 

The Name Of The Publisher:

APH India

Malhotra Pub. House

 

 

 

 

 

Number Of Book Chapters In Edited Books Of International Publishers :

12

 

 

 

 

 

The Name Of The Publisher :

SPRINGER Nature

Springer International

Academic Press

ICRISAT

 

 

 

 

 

RESEARCH GRANTS AND CONSULTANCY PROJECTS

Number Of Research Grants From Govt. Funding Agencies As PI/Coordinator :

8

 

 

 

 

Name Of The Agency And Amount Of Funding Generated :

Department of Biotechnology  (BT),    Rs. 64 Lakhs;  Rs. 178 Lakhs;

Department of Science and Techology SERB  (DST-SERB),   Rs. 64 Lakhs;

Indian Council of Medical Research (ICMR),    Rs. 42 Lakhs;  Rs. 50 Lakhs;    Rs. 110 Lakhs;  Rs. 6 Lakhs;

Biotechnology Industry Research Assistance Council (BIRAC)   Rs. 127 Lakhs;

 

 

 

 

Number Of Research Grants From Govt. Funding Agencies As Co-PI :

2

 

 

 

 

Name Of The Agency And Amount Of Funding Generated :

Department of Biotechnology  (BT),    Rs. 153 Lakhs;  Rs. 99 Lakhs;

Indian Council of Medical Research (ICMR),   Rs. 26.38 Lakhs;

 

 

 

Number Of Research Grants From International And Private Sources As PI :

3

 

 

 

 

Name Of The Agency And Amount Of Funding Generated :

Number Of Consultancy Projects :

Name Of The Agency And Amount Of Funding Generated :

RESEARCH SUPERVISION

Number Of Master’s Theses/DissertationsGuided :

18

 

 

Number Of Ph.D. Guided :

5

 

 
Number Of Master’s Theses/DissertationsGuided :
Number Of Co-supervisorPhd :

2

 

 

PATENTS

Number Of Patents Granted :

4

 

 
Specify National/International :

3 of them were International

1 of it was National

 

 
Number Of Patents Applied For :
Specify National/International :

PRESENTATIONS IN CONFERENCES AS SPEAKER/ RESOURCE PERSON

Number Of Presentations In National Or International Conferences In India :

5 International Conferences in India

13 National Conferences in India

 

 
Please Specify Invited/Oral/Poster :

All of them were INVITED/ORAL

 

 
Number Of Presentations In International Conferences Abroad :

9 International Conferenes in Abroad

 
Please Specify Invited/Oral/Poster :

All of them were INVITED/ORAL

 

NATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED

Name Of The Award :

Best Researcher Award

Fellow of Academy Medical of Sciences (FAMS)

 

Granting Agency :

Galgotias University, Greater Noida, UP, India

 

National Academy Medical of Sciences, India

 

 

Year Of Award :

2024

2024

 

 

INTERNATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED

Name Of The Award :

ORISE Fellowship to work in FDA, USA

Fellows award for Research Excellence (FARE)

Group Recognition Award’ to Chagas Disease Donor Screening Biological License  Application Review Group

Centre Director’s Scientific Achievement Award

 

Granting Agency :

National Institute of Health, Bethesda MD USA

National Institute of Health, Bethesda MD USA

CBER/Food and Drug Administration, MD, USA

CBER/Food and Drug Administration, MD, USA

 

Year Of Award :

1999

2002

2007

2009

 

STAFF DEVELOPMENT/REFRESHER/SHORT TERM TRAINING PROGRAMME/WEBINARS ORGANIZED

Title :

Duration :

Sponsoring Agency :

MEMBER(S) OF NATIONALCOMMITTEES

Life Member of Indian Immunology Society, India

Life Member of Indian Parasitology Society, India

Life Member of Indian Cell Biology Society, India

 

 

MEMBER(S) OF INTERNATIONAL COMMITTEES

American Association of Immunologists, USA  (2017)

American Society of Cell Biology, USA  (2002-2007)

 

 

ADMINISTARTIVE RESPONSIBILITIES/ PARTICIPATION IN COMMITTEES OF JAMIA HAMDARD

As In-charge, JH Institute of Molecular Medicine, (2016-2019)

As Head, Department of Molecular Medicine, (2019-2022)

As Head, Department of Food Technology, (2019-2021)

As In-charge, Centre for Virology, (2023-2023)

As Dean, School of Interdisciplinary Sciences and Technology (2024-......)

 

 

ANY OTHER

Select list of publications of last 5 years

  1. Roshanara, Tandon, R., Puri, N., & Selvapandiyan, A. (2024). Mechanistic insights into LdCen1-LdDRP interaction facilitating UV-induced DNA damage repair in Leishmania donovaniMedical Microbiology and Immunology (In press).

  2. Selvapandiyan, A., Shital, S., Sangma, D. A., Jain, M., Karunaweera, N., & Ganguly, N. K. (2025). An update on clinical and pathogenic spectra of leishmaniasis. Expert Review of Molecular Medicine, 1–33.

  3. Orucho, V. O., Gupta, A., Masai, R. J., Ondari, E., Singh, O. P., Nyagaka, B., & Selvapandiyan, A. (2024). Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa. Diagnostic Microbiology and Infectious Disease, 111(3), 116655. https://doi.org/10.1016/j.diagmicrobio.2024.116655

  4. Shital, M., E., Selvapandiyan, A., & Ganguly, N. K. (2024). An update on recombinant vaccines against leishmaniasis. Indian Journal of Medical Sciences (In press). https://doi.org/10.4103/ijms.ijms_1234_24

  5. Roshanara, Tandon, R., Baig, M. S., Das, S., Srivastava, R., Puri, N., Nakhasi, H. L., & Selvapandiyan, A. (2024). Identifying Rab2 protein as a key interactor of Centrin1 essential for Leishmania donovani growth. ACS Infectious Diseaseshttps://doi.org/10.1021/acsinfecdis.39110117

  6. Avishek, K., Beg, M. A., Vats, K., Singh, A. K., Dey, R., Singh, K. P., Singh, R. K., Gannavaram, S., Ramesh, V., Mulla, M. S. A., Bhatnagar, U., Singh, S., Nakhasi, H. L., & Salotra, P., & Selvapandiyan, A. (2024). Manufacturing and preclinical toxicity of GLP-grade gene-deleted attenuated Leishmania donovani parasite vaccine. Scientific Reports, 14(1), 14636.

  7. Reyaz, E., Tandon, R., Beg, M. A., Dey, R., Puri, N., Salotra, P., Nakhasi, H. L., & Selvapandiyan, A. (2024). Proteome profile of Leishmania donovani Centrin1-/- parasite-infected human macrophage cells and implications in protective immunity. Microbes and Infectious Diseases, 105340. https://doi.org/10.1016/j.micinf.2024.105340

  8. Roshanara, Muthu, S. A., Gulafsha, Tandon, R., & Selvapandiyan, A. (2024). Biophysical evidence for the amyloid formation of a recombinant Rab2 isoform of Leishmania donovaniProtein and Peptide Lettershttps://doi.org/10.2174/0109298665299157240327084614

  9. Reyaz, E., Puri, N., & Selvapandiyan, A. (2024). Global remodeling of host proteome in response to Leishmania infection. ACS Infectious Diseases, 10(1), 5–19.

  10. Madusanka, R. K., Hermali, N., & Selvapandiyan, A. (2023). Antimony resistance and gene expression in Leishmania: Insights from molecular and proteomic studies. Parasitology, 151(1), 1–14. https://doi.org/10.1017/S0031182023001129

  11. Tandon, R., Reyaz, E., Roshanara, M., Jadhav, M., Gandhi, R., Dey, R., Salotra, P., Nakhasi, H. L., & Selvapandiyan, A. (2023). Identification of protein biomarkers of attenuation and immunogenicity of Leishmania centrin or p27 gene-deleted live vaccine candidates. Parasitology International, 92, 102661.

  12. Vats, K., Tandon, R., Roshanara, M. A., Beg, M., Corrales, R. M., Yagoubat, A., Reyaz, E., Wani, T. H., Baig, M. S., Chaudhury, A., Krishnan, A., Puri, N., Salotra, P., Sterkers, Y., & Selvapandiyan, A. (2023). Interaction of novel proteins, centrin4 and a protein of the centriole, in Leishmania parasite and their effects on parasite growth. Biochimica et Biophysica Acta - Molecular Cell Research, 1870, 119416.

  13. Selvapandiyan, A., Puri, N., Kumar, P., Alam, A., Ehtesham, N. Z., Griffin, G., & Hasnain, S. E. (2022). Zooming in on common immune evasion mechanisms of pathogens in phagolysosomes: Potential broad-spectrum therapeutic targets against infectious diseases. FEMS Microbiology Reviews, 47.

  14. Gupta, A., Sinha, K. M., Abdin, M. J., Puri, N., & Selvapandiyan, A. (2021). NDK/NME proteins: A host-pathogen interface perspective towards therapeutics. Current Genetics, 67, 1–12. https://doi.org/10.1007/s00294-021-01198-9

  15. Ahuja, K., Vats, A., Beg, M. A., Kariyawasam, K. K. G. D. U. L., Chaudhury, A., Chatterjee, M., Dey, N. D., & Selvapandiyan, A. (2020). High-resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis. Parasitology International, 75, 102047.

  16. Chauhan, C., Singh, P., Muthu, S. A., Parvez, S., Selvapandiyan, A., & Ahmad, B. (2024). Plumbagin accelerates serum albumin amyloid aggregation kinetics and induces fibril polymorphism by promoting non-native β-sheet structures. Biochimica et Biophysica Acta - Proteins and Proteomics, 141028. https://doi.org/10.1016/j.bbapap.2024.141028

  17. Jain, P., Mirza, M. A., Reyaz, E., Beg, M. A., Selvapandiyan, A., Ahmad, F. J., & Iqbal, Z. (2024). QbD-assisted development and optimization of doxycycline hyclate- and hydroxyapatite-loaded nanoparticles for periodontal delivery. ACS Omega, 9(4), 4455–4465.

  18. Ghosh, S., Kumar, V., Verma, A., Sharma, T., Pradhan, D., Selvapandiyan, A., & Salotra, P. (2022). Genome-wide analysis reveals allelic and chromosome copy number variation in paromomycin-resistant Leishmania donovaniParasitology Research, 121(11), 3121–3132.

  19. Ghosh, S., Verma, A., Kumar, V., Pradhan, D., Selvapandiyan, A., Salotra, P., & Singh, R. (2020). Genomic and transcriptomic analysis for identifying genes and pathways mediating artemisinin resistance in Leishmania donovaniGenes, 11(11), 1362. https://doi.org/10.3390/genes11111362

  20. Naqvi, N., Srivastava, R., Selvapandiyan, A., & Puri, N. (2020). Host mast cells in leishmaniasis: Friend or foe? Trends in Parasitology, 36(12), 952–956. https://doi.org/10.1016/j.pt.2020.09.010

  21. Zafar, S., Akhter, S., Garg, N., Selvapandiyan, A., Jain, G. K., & Ahmad, F. J. (2020). Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity. European Journal of Pharmaceutics and Biopharmaceutics, 148, 10–26. https://doi.org/10.1016/j.ejpb.2019.12.016

 

Angamuthu Selvapandiyan

Email : selvapandiyan@jamiahamdard.ac.in

View Google Scholar

PERSONAL INFORMATION

Alternate Email :

aselvapandiyan@gmail.com

Designation :

Dean, HOD & Professor

Department & School :

Department of Molecular Medicine, School of Interdisciplinary Sciences and Technology

Qualifications :

Ph.D. FAMS

State Of Domicile :

Delhi

Research Thrust Areas :

Infectious Diseases, Cell Biology, Vaccinolgy, Drug Development

Details Of Courses Taught

Vaccinology, Immunology,Parasitology, Bacteriology, Molecular Biology

PUBLICATIONS

BOOKS & BOOK CHAPTERS PUBLISHED

Number Of Books Published By National Publisher :

The Name Of The Publisher :

Number Of Books Published By International Publisher :

1

 

 

 

 

 

The Name Of The International Publisher :

SPRINGER 

 

 

 

 

Number Of Book Chapters In Edited Books Of National Publishers :

4

 

 

 

 

 

The Name Of The Publisher:

APH India

Malhotra Pub. House

 

 

 

 

 

Number Of Book Chapters In Edited Books Of International Publishers :

12

 

 

 

 

 

The Name Of The Publisher :

SPRINGER Nature

Springer International

Academic Press

ICRISAT

 

 

 

 

 

RESEARCH GRANTS AND CONSULTANCY PROJECTS

Number Of Research Grants From Govt. Funding Agencies As PI/Coordinator :

8

 

 

 

 

Name Of The Agency And Amount Of Funding Generated :

Department of Biotechnology  (BT),    Rs. 64 Lakhs;  Rs. 178 Lakhs;

Department of Science and Techology SERB  (DST-SERB),   Rs. 64 Lakhs;

Indian Council of Medical Research (ICMR),    Rs. 42 Lakhs;  Rs. 50 Lakhs;    Rs. 110 Lakhs;  Rs. 6 Lakhs;

Biotechnology Industry Research Assistance Council (BIRAC)   Rs. 127 Lakhs;

 

 

 

 

Number Of Research Grants From Govt. Funding Agencies As Co-PI :

2

 

 

 

 

Name Of The Agency And Amount Of Funding Generated :

Department of Biotechnology  (BT),    Rs. 153 Lakhs;  Rs. 99 Lakhs;

Indian Council of Medical Research (ICMR),   Rs. 26.38 Lakhs;

 

 

 

Number Of Research Grants From International And Private Sources As PI :

3

 

 

 

 

Name Of The Agency And Amount Of Funding Generated :

Number Of Consultancy Projects :

Name Of The Agency And Amount Of Funding Generated :

RESEARCH SUPERVISION

Number Of Master’s Theses/DissertationsGuided :

18

 

 

Number Of Ph.D. Guided :

5

 

 
Number Of Master’s Theses/DissertationsGuided :
Number Of Co-supervisorPhd :

2

 

 

PATENTS

Number Of Patents Granted :

4

 

 
Specify National/International :

3 of them were International

1 of it was National

 

 
Number Of Patents Applied For :
Specify National/International :

PRESENTATIONS IN CONFERENCES AS SPEAKER/ RESOURCE PERSON

Number Of Presentations In National Or International Conferences In India :

5 International Conferences in India

13 National Conferences in India

 

 
Please Specify Invited/Oral/Poster :

All of them were INVITED/ORAL

 

 
Number Of Presentations In International Conferences Abroad :

9 International Conferenes in Abroad

 
Please Specify Invited/Oral/Poster :

All of them were INVITED/ORAL

 

NATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED

Name Of The Award :

Best Researcher Award

Fellow of Academy Medical of Sciences (FAMS)

 

Granting Agency :

Galgotias University, Greater Noida, UP, India

 

National Academy Medical of Sciences, India

 

 

Year Of Award :

2024

2024

 

 

INTERNATIONAL AWARDS, HONOURS AND FELLOWSHIPS RECEIVED

Name Of The Award :

ORISE Fellowship to work in FDA, USA

Fellows award for Research Excellence (FARE)

Group Recognition Award’ to Chagas Disease Donor Screening Biological License  Application Review Group

Centre Director’s Scientific Achievement Award

 

Granting Agency :

National Institute of Health, Bethesda MD USA

National Institute of Health, Bethesda MD USA

CBER/Food and Drug Administration, MD, USA

CBER/Food and Drug Administration, MD, USA

 

Year Of Award :

1999

2002

2007

2009

 

STAFF DEVELOPMENT/REFRESHER/SHORT TERM TRAINING PROGRAMME/WEBINARS ORGANIZED

Title :

Duration :

Sponsoring Agency :

MEMBER(S) OF NATIONALCOMMITTEES

Life Member of Indian Immunology Society, India

Life Member of Indian Parasitology Society, India

Life Member of Indian Cell Biology Society, India

 

 

MEMBER(S) OF INTERNATIONAL COMMITTEES

American Association of Immunologists, USA  (2017)

American Society of Cell Biology, USA  (2002-2007)

 

 

ADMINISTARTIVE RESPONSIBILITIES/ PARTICIPATION IN COMMITTEES OF JAMIA HAMDARD

As In-charge, JH Institute of Molecular Medicine, (2016-2019)

As Head, Department of Molecular Medicine, (2019-2022)

As Head, Department of Food Technology, (2019-2021)

As In-charge, Centre for Virology, (2023-2023)

As Dean, School of Interdisciplinary Sciences and Technology (2024-......)

 

 

ANY OTHER

Select list of publications of last 5 years

  1. Roshanara, Tandon, R., Puri, N., & Selvapandiyan, A. (2024). Mechanistic insights into LdCen1-LdDRP interaction facilitating UV-induced DNA damage repair in Leishmania donovaniMedical Microbiology and Immunology (In press).

  2. Selvapandiyan, A., Shital, S., Sangma, D. A., Jain, M., Karunaweera, N., & Ganguly, N. K. (2025). An update on clinical and pathogenic spectra of leishmaniasis. Expert Review of Molecular Medicine, 1–33.

  3. Orucho, V. O., Gupta, A., Masai, R. J., Ondari, E., Singh, O. P., Nyagaka, B., & Selvapandiyan, A. (2024). Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa. Diagnostic Microbiology and Infectious Disease, 111(3), 116655. https://doi.org/10.1016/j.diagmicrobio.2024.116655

  4. Shital, M., E., Selvapandiyan, A., & Ganguly, N. K. (2024). An update on recombinant vaccines against leishmaniasis. Indian Journal of Medical Sciences (In press). https://doi.org/10.4103/ijms.ijms_1234_24

  5. Roshanara, Tandon, R., Baig, M. S., Das, S., Srivastava, R., Puri, N., Nakhasi, H. L., & Selvapandiyan, A. (2024). Identifying Rab2 protein as a key interactor of Centrin1 essential for Leishmania donovani growth. ACS Infectious Diseaseshttps://doi.org/10.1021/acsinfecdis.39110117

  6. Avishek, K., Beg, M. A., Vats, K., Singh, A. K., Dey, R., Singh, K. P., Singh, R. K., Gannavaram, S., Ramesh, V., Mulla, M. S. A., Bhatnagar, U., Singh, S., Nakhasi, H. L., & Salotra, P., & Selvapandiyan, A. (2024). Manufacturing and preclinical toxicity of GLP-grade gene-deleted attenuated Leishmania donovani parasite vaccine. Scientific Reports, 14(1), 14636.

  7. Reyaz, E., Tandon, R., Beg, M. A., Dey, R., Puri, N., Salotra, P., Nakhasi, H. L., & Selvapandiyan, A. (2024). Proteome profile of Leishmania donovani Centrin1-/- parasite-infected human macrophage cells and implications in protective immunity. Microbes and Infectious Diseases, 105340. https://doi.org/10.1016/j.micinf.2024.105340

  8. Roshanara, Muthu, S. A., Gulafsha, Tandon, R., & Selvapandiyan, A. (2024). Biophysical evidence for the amyloid formation of a recombinant Rab2 isoform of Leishmania donovaniProtein and Peptide Lettershttps://doi.org/10.2174/0109298665299157240327084614

  9. Reyaz, E., Puri, N., & Selvapandiyan, A. (2024). Global remodeling of host proteome in response to Leishmania infection. ACS Infectious Diseases, 10(1), 5–19.

  10. Madusanka, R. K., Hermali, N., & Selvapandiyan, A. (2023). Antimony resistance and gene expression in Leishmania: Insights from molecular and proteomic studies. Parasitology, 151(1), 1–14. https://doi.org/10.1017/S0031182023001129

  11. Tandon, R., Reyaz, E., Roshanara, M., Jadhav, M., Gandhi, R., Dey, R., Salotra, P., Nakhasi, H. L., & Selvapandiyan, A. (2023). Identification of protein biomarkers of attenuation and immunogenicity of Leishmania centrin or p27 gene-deleted live vaccine candidates. Parasitology International, 92, 102661.

  12. Vats, K., Tandon, R., Roshanara, M. A., Beg, M., Corrales, R. M., Yagoubat, A., Reyaz, E., Wani, T. H., Baig, M. S., Chaudhury, A., Krishnan, A., Puri, N., Salotra, P., Sterkers, Y., & Selvapandiyan, A. (2023). Interaction of novel proteins, centrin4 and a protein of the centriole, in Leishmania parasite and their effects on parasite growth. Biochimica et Biophysica Acta - Molecular Cell Research, 1870, 119416.

  13. Selvapandiyan, A., Puri, N., Kumar, P., Alam, A., Ehtesham, N. Z., Griffin, G., & Hasnain, S. E. (2022). Zooming in on common immune evasion mechanisms of pathogens in phagolysosomes: Potential broad-spectrum therapeutic targets against infectious diseases. FEMS Microbiology Reviews, 47.

  14. Gupta, A., Sinha, K. M., Abdin, M. J., Puri, N., & Selvapandiyan, A. (2021). NDK/NME proteins: A host-pathogen interface perspective towards therapeutics. Current Genetics, 67, 1–12. https://doi.org/10.1007/s00294-021-01198-9

  15. Ahuja, K., Vats, A., Beg, M. A., Kariyawasam, K. K. G. D. U. L., Chaudhury, A., Chatterjee, M., Dey, N. D., & Selvapandiyan, A. (2020). High-resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis. Parasitology International, 75, 102047.

  16. Chauhan, C., Singh, P., Muthu, S. A., Parvez, S., Selvapandiyan, A., & Ahmad, B. (2024). Plumbagin accelerates serum albumin amyloid aggregation kinetics and induces fibril polymorphism by promoting non-native β-sheet structures. Biochimica et Biophysica Acta - Proteins and Proteomics, 141028. https://doi.org/10.1016/j.bbapap.2024.141028

  17. Jain, P., Mirza, M. A., Reyaz, E., Beg, M. A., Selvapandiyan, A., Ahmad, F. J., & Iqbal, Z. (2024). QbD-assisted development and optimization of doxycycline hyclate- and hydroxyapatite-loaded nanoparticles for periodontal delivery. ACS Omega, 9(4), 4455–4465.

  18. Ghosh, S., Kumar, V., Verma, A., Sharma, T., Pradhan, D., Selvapandiyan, A., & Salotra, P. (2022). Genome-wide analysis reveals allelic and chromosome copy number variation in paromomycin-resistant Leishmania donovaniParasitology Research, 121(11), 3121–3132.

  19. Ghosh, S., Verma, A., Kumar, V., Pradhan, D., Selvapandiyan, A., Salotra, P., & Singh, R. (2020). Genomic and transcriptomic analysis for identifying genes and pathways mediating artemisinin resistance in Leishmania donovaniGenes, 11(11), 1362. https://doi.org/10.3390/genes11111362

  20. Naqvi, N., Srivastava, R., Selvapandiyan, A., & Puri, N. (2020). Host mast cells in leishmaniasis: Friend or foe? Trends in Parasitology, 36(12), 952–956. https://doi.org/10.1016/j.pt.2020.09.010

  21. Zafar, S., Akhter, S., Garg, N., Selvapandiyan, A., Jain, G. K., & Ahmad, F. J. (2020). Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity. European Journal of Pharmaceutics and Biopharmaceutics, 148, 10–26. https://doi.org/10.1016/j.ejpb.2019.12.016

 

Designed & Devloped by HAH-CIT

© 2025 Jamia Hamdard

V I S I T O R S : - 2 7 9 4 8 4 3